Wellspring Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.94M Sell
11,668
-85
-0.7% -$18.3K 0.19% 50
2026
Q1
$2.56M Buy
11,753
+1,005
+9% +$223K 0.19% 53
2025
Q4
$2.46M Buy
10,748
+6,281
+141% +$1.43M 0.19% 50
2025
Q3
$1.03M Buy
4,467
+675
+18% +$137K 0.1% 65
2025
Q2
$704K Buy
3,792
+142
+4% +$26.4K 0.07% 71
2025
Q1
$765K Buy
3,650
+831
+29% +$162K 0.09% 62
2024
Q4
$501K Sell
2,819
-135
-5% -$24.8K 0.05% 75
2024
Q3
$583K Sell
2,954
-499
-14% -$93.1K 0.07% 76
2024
Q2
$592K Buy
3,453
+660
+24% +$109K 0.08% 74
2024
Q1
$509K Buy
2,793
+270
+11% +$46.5K 0.08% 70
2023
Q4
$391K Sell
2,523
-164
-6% -$23.9K 0.1% 82
2023
Q3
$401K Sell
2,687
-366
-12% -$53.7K 0.12% 69
2023
Q2
$411K Buy
3,053
+198
+7% +$29K 0.12% 65
2023
Q1
$455K Sell
2,855
-61
-2% -$9.33K 0.14% 67
2022
Q4
$471K Buy
2,916
+95
+3% +$14.6K 0.16% 62
2022
Q3
$379K Buy
2,821
+17
+0.6% +$2.44K 0.14% 57
2022
Q2
$429K Sell
2,804
-85
-3% -$13K 0.15% 54
2022
Q1
$468K Buy
2,889
+18
+0.6% +$2.62K 0.14% 56
2021
Q4
$389K Buy
2,871
+87
+3% +$10.3K 0.11% 64
2021
Q3
$300K Buy
2,784
+20
+0.7% +$2.29K 0.09% 76
2021
Q2
$311K Buy
+2,764
New +$311K 0.1% 71
2021
Q1
Sell
-2,723
Closed -$292K 90
2020
Q4
$292K Buy
2,723
+11
+0.4% +$1.06K 0.1% 70
2020
Q3
$238K Buy
2,712
+6
+0.2% +$565 0.09% 77
2020
Q2
$266K Buy
+2,706
New +$238K 0.11% 75

Other funds holding ABBV

Wellspring Financial Advisors's ABBV Position: Q2 2026 in Review

Wellspring Financial Advisors reduced its AbbVie (ABBV) stake by 0.72% in Q2 2026, selling an estimated $18.3K and leaving 11,668 shares worth $2.94M. The position accounts for 0.19% of the portfolio, ranked #50.

Wellspring Financial Advisors first reported a position in ABBV in Q2 2020 and has held it in 24 quarters since. 1,493 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Wellspring Financial Advisors held 11,668 shares of AbbVie worth $2.94M as of Q2 2026.
  • Wellspring Financial Advisors sold 85 AbbVie shares in Q2 2026, an estimated $18.3K.
  • AbbVie made up 0.19% of Wellspring Financial Advisors's portfolio in Q2 2026, its #50 holding.
  • Wellspring Financial Advisors first reported a position in AbbVie in Q2 2020 and has held it in 24 quarters since.
  • 1,493 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wellspring Financial Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.